Herbs protect against osteoporosis through anti-inflammation action

doi:10.3969/j.issn.2095-4344.0103

Abstract

Abstract:

BACKGROUND: The occurrence and development of osteoporosis are shown to be directly related to the inflammatory response induced by immune dysfunction.
OBJECTIVE: To summarize the mechanisms of osteoclast differentiation and formation at cellular and molecular levels, as well as the underlying mechanisms of several kinds of medical herbs against osteoporosis, thus paving ways for finding more effective and safe herbs for anti-osteoporosis.
METHODS: PubMed database was retrieved using the English keywords of (osteoporosis OR bone loss) AND lipopolysaccharide AND bone resorption”, and WanFang database was searched with the Chinese keywords of “osteoarthritis, receptor activator of nuclear factor-κB ligand, lipopolysaccharide, Dendrobium moniliforme, Portulaca oleracea, Ampelopsis sinica, Schizonepeta”. The literatures addressing osteoporosis, inflammation and herbal medicine were screened, and those using lipopolysaccharide-induced mouse models were included. Finally, four eligible literatures were enrolled for review.
RESULTS AND CONCLUSION: In vivo experiments, CT images and pathological sections of the cancellous bone in the mouse distal femur show that Dendrobium moniliforme, Purslane oleracea, Ampelopsis sinica, and Schizonepeta exert inhibitory effects on lipopolysaccharide-induced osteoporosis. In vitro experiments reveal that these four kinds of herbs fight against osteoporosis by inhibiting osteoclast differentiation and further reducing bone resorption.

中国组织工程研究杂志出版内容重点：组织构建；骨细胞；软骨细胞；细胞培养；成纤维细胞；血管内皮细胞；骨质疏松；组织工程

Key words: Osteoporosis, Drugs, Chinese Herbal, Dendrobium, Portulaca, Lamiaceae, Tissue Engineering

CLC Number:

R318

Yang Yuan-chao1, Wang Ying2, Fang Zhi-yuan2, Liu Xue-wei2, Sheng Tong2, Wang Xin-xiang2. Herbs protect against osteoporosis through anti-inflammation action[J]. Chinese Journal of Tissue Engineering Research, 2018, 22(4): 638-643.

Figures/Tables 2

References

[1] 钱兴皋,刘宇恒,王琴,等.炎症因子对骨质疏松症发病影响的研究进展[J].中国康复理论与实践,2013,19(7):645-646.

[2] 夏婷,李双庆.炎症相关骨质疏松症的发病机制[J].中国骨质疏松杂志,2015,21(1):117-120.

[3] 杜艳萍,程群.炎症在骨质疏松发生中的作用与机制研究新进展[J].老年医学与保健,2013,19(6):427-431.

[4] 王凌.骨质疏松症的炎症机制[C].全国中西医结合生殖系统炎症性疾病专题学术会议论文集,贵阳:2013:43-50.

[5] 邹世恩,张绍芬.细胞因子在绝经后骨质疏松症发病机制中的作用[J].中国骨质疏松杂志,2012,18(4):375-380.

[6] 刘连勇,郑胜喜,甄燕,等. 原发性骨质疏松症的骨骼免疫机制研究进展[J]. 中国骨质疏松杂志,2016,22(7):912-917.

[7] 常志芳,冯成龙,史晓霞,等. 免疫与骨质疏松的研究进展[J].中国骨质疏松杂志,2015,21(4):508-513.

[8] 欧国峰,刘鑫,董博,等.绝经后骨质疏松症的免疫学研究进展[J].中医正骨,2016,28(8):70-72.

[9] 李文艳,徐玉善,李红.免疫调节在骨质疏松症中的研究进展[J].医学综述,2015,21(2):213-216.

[10] 章岚,陈勇.慢性持续性低度炎症与运动、健康和疾病的研究进展[J].北京体育大学学报,2014,37(8):71-76.

[11] 叶翎,孙国燕,孙玉瑶,等.慢性低度炎症与糖尿病关系的研究进展[J].医学综述,2014,20(21):3846-3848.

[12] Robinson WH, Lepus CM, Wang Q,et al.Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis.Nat Rev Rheumatol.2016 10;12(10):580-592.

[13] Chronic Disease; Controlling inflammation to reduce chronic disease risk. Obesity & Diabetes Week 2015 Aug 24:6.

[14] Erbas O,Akseki H,Aktu H,et al.Low-grade chronic inflammation induces behavioral stereotypy in rats. Metab Brain Dis 2015;30(3):739-746.

[15] Frank MO, Caceres BA. Inflammaging: A Concept Analysis. The Journal for Nurse Practitioners.2015;11(2):258-261.

[16] Ilich JZ, Kelly OJ, Kim Y, et al. Low-grade chronic inflammation perpetuated by modern diet as a promoter of obesity and osteoporosis.ArhHig Rada Toksikol. 2014; 65(2):139-148.

[17] Wärnberg J, Cunningham K, Romeo J,et al. Physical activity, exercise and low-grade systemic inflammation. Proc Nutr Soc. 2010;69(3):400-406.

[18] Kolb H, Mandrup-poulsen T.The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation. Diabetologia.2010;53(1):10-20.

[19] Costello-white R, Ryff CD, Coe CL. Aging and low-grade inflammation reduce renal function in middle-aged and older adults in Japan and the USA. Age (Dordr). 2015 ;37(4):9808.

[20] Novack DV,Faccio R.Osteoclast motility: putting the brakes on bone resorption.Ageing Res Rev.2011;10(1):54-61.

[21] Jabbar S，Drury J，Fordham JN，et al．Osteoprotegerin，RANKL and bone turnover in postmenopausal osteoporosis．J ClinPathol.2011;64( 4) : 354-357.

[22] Trouvin AP, Goëb V．Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss．ClinInterv Aging.2010;19(5): 345-354.

[23] Blumenfeld O, Williams FM, Valdes A, et al.Association of interleukin-6 gene polymorphisms with hand osteoarthritis and hand osteoporosis.Cytokine.2014; 69:94-101.

[24] Ivanova JT, Boyanov MA, Toshev AK. Polymorphisms of the human IL-1 receptor antagonist gene and forearm bone mineral density in postmenopausal women. Indian J EndocrMetab.2012; 16:580-584.

[25] 常睿洁.骨质疏松症的中西药治疗进展[J].中国新药杂志,2015, 4(13):1498-1503.

[26] 张燕燕,卢春燕,刘斌,等.骨质疏松症的药物治疗[J]．中国骨质疏松杂志,2007,13(11):809-813．

[27] van Staa TP, Leufkens HG, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. OsteoporosInt.2002;13(10):777-787.

[28] Boyle WJ,Simonet WS,Lacey DL.Osteoclast differentiation and activation.Nature. 2003;423(6937):337-342.

[29] Suda T,Kobayashi K,Jimi E,et al.The molecularbasis of osteoclast differentiation and activation. Novartis Found Symp. 2001;232:235-247.

[30] Wada T,Nakashima T,Hiroshi N,et al. RANKL-RANK signaling inosteoclastogenesis and bone disease. Trends Mol Med. 2006;12(1):17-25.

[31] Takayanagi H, Kim S, Koga T,et al. Inductionand activation of the transcription factor NFATc1 (NFAT2) integrateRANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 2002;3(6):889-901.

[32] Rodan SB,Rodan GA.Integrin function in osteoclasts.J Endocrinol.1997;154(Suppl):S47-56.

[33] Yagi M, Miyamoto T, Sawatani Y, et al.DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign bodygiant cells. J Exp Med.2005;202(3):345-351.

[34] Goto T,Yamaza T,Tanaka T.Cathepsins in the osteoclast.J Electron Microsc(Tokyo). 2003;52(6):551-558.

[35] Suda K,Woo JT,Takami M,et al. Lipopolysaccharide supportssurvival and fusion of preosteoclasts independent of TNF-alpha, IL-1, andRANKL. J Cell Physiol. 2002;190(1): 101-108.

[36] Sakuma Y, Tanaka K, Suda M,et al. Impaired boneresorption by lipopolysaccharide in vivo in mice deficient in theprostaglandin E receptor EP4 subtype. Infect Immun. 2000;68(12):6819-6825.

[37] Orcel P, Feuga M, Bielakoff J, et al. Local bone injections of LPSand M-CSF increase bone resorption by different pathways in vivo in rats.Am J Physiol. 1993;264(3 Pt 1): E391-397.

[38] Lee W,Eom DW,Jung Y,et al.Dendrobiummoniliforme attenuates high-fat diet-induced renal damage in mice through the regulation oflipid-induced oxidative stress. Am J Chin Med.2012;40:1217-1228.

[39] Baek JM , Kim JY , Ahn SJ , et al. Dendrobium moniliforme Exerts Inhibitory Effects on Both Receptor Activator of Nuclear Factor Kappa-B Ligand-Mediated Osteoclast Differentiation in Vitro and Lipopolysaccharide-Induced Bone Erosion in Vivo.Molecules.2016;21(3):295.

[40] Uddin MK, Juraimi AS, Hossain MS,et al. Purslane weed (Portulacaoleracea): a prospective plantsource of nutrition, omega-3 fatty acid, and antioxidant attributes. Scientific World J. 2014;2014:951019

[41] Chan K, Islam MW, Kamil M,et al. The analgesic and anti-inflammatory effectsof Portulacaoleracea L. ssp. Sativa (HAW.)CELAK. J Ethnopharmacol. 2000;73(3):445-451.

[42] Silva R, Carvalho IS.In vitro antioxidant activity, phenolic compoundsand protective effect against DNA damage provided byleaves, stems and flowers of Portulacaoleracea (PURSLANE). Nat Prod Commun. 2014;9(1):45-50.

[43] Kim JY, Oh HM, Kwak SC, et al. Purslane suppresses osteoclast differentiation and bone resorbing activity via inhibition of Akt/GSK3β-c-Fos-NFATc1 signaling in vitro and prevents lipopolysaccharide-induced bone loss in vivo. Biol Pharm Bull. 2015;38(1):66-74.

[44] Cao H, Zhu K, Qiu L,et al.Criticalrole of AKT protein in myeloma-induced osteoclast formation andosteolysis. J Biol Chem. 2013;288(42):30399-30410.

[45] Moon JB, Kim JH, Kim K,et al.Aktinduces osteoclast differentiation through regulating the GSK3beta/NFATc1 signaling cascade. J Immunol. 2012;188(1):163-169.

[46] Kim JY, Park SH, Oh HM, et al.Ampelopsisbrevipedunculata Extract Prevents Bone Loss byInhibiting Osteoclastogenesis in Vitro and in Vivo. Molecules. 2014;19(11):18465-18478.

[47] Idris AI, Krishnan M, Simic P,et al.Small molecule inhibitors of IkappaB kinase signaling inhibit osteoclastformation in vitro and prevent ovariectomy-induced bone loss in vivo.FASEB J.2010;24(11):4545-4555.

[48] Byun MW.Schizonepetatenuifolia ethanol extract exerts anti-inflammatoryactivity through the inhibition of TLR4 signaling in lipopolysaccharidestimulatedmacrophage cells.J Med Food.2014;17(3):350-356.

[49] Wang BS,Huang GJ, Tai HM,et al. Antioxidant and anti-inflammatoryactivities of aqueous extracts of SchizonepetatenuifoliaBriq.Food ChemToxicol. 2012;50(3-4): 526-531.

[50] Kim JY, Baek JM, Ahn SJ, et al.Ethanolic extract of Schizonepetatenuifoliaattenuates osteoclast formation and activation in vitro and protects againstlipopolysaccharide- induced bone loss in vivo. BMC Complement Altern Med. 2016;16(1):301.

[51] Hadjidakis DJ,Androulakis II.Bone remodeling.Ann N Y Acad Sci.2006;1092:385–396.

[52] Tanaka Y, Nakayamada S, Okada Y. Osteoblasts and osteoclasts in boneremodeling and inflammation. Curr Drug Targets Inflamm Allergy.2005;4(3):325-328.